A new lens on clinical trials

In 2014, the health industry comes under increasing pressure to replenish its product pipeline faster and with fewer dollars.

To speed up clinical trials and reduce costs, drug developers, device makers and contract researchers are poised to take advantage of alternative approaches for clinical trials, such as adaptive designs and precision medicine.

Read more in HRI’s 10Minutes industry series Drug value in the new health ecosystem.

What are the implications?

Research and development remains an economic engine in the eyes of consumers
Share this Twitter Linkedin Facebook

Implications of new clinical trial models:

  • A skilled workforce is key in embracing new trial methods.
  • Trial sponsors should apply the “patient-centered” concept to trial design to stimulate engagement.
  • Virtual models and simulations may identify potential risks, outcomes, and biomarkers that can diminish setbacks and lower costs.